BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061G951. A total of 5 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $357,000 | -71.4% | 4,000 | -70.1% | 0.02% | -80.2% |
| Q3 2017 | $1,247,000 | -35.9% | 13,400 | -37.4% | 0.12% | +58.9% |
| Q2 2017 | $1,944,000 | +31.8% | 21,400 | +27.4% | 0.07% | +563.6% |
| Q1 2017 | $1,475,000 | +47.2% | 16,800 | +38.8% | 0.01% | +120.0% |
| Q4 2016 | $1,002,000 | -42.1% | 12,100 | -35.3% | 0.01% | -37.5% |
| Q3 2016 | $1,730,000 | +19.6% | 18,700 | +0.5% | 0.01% | +14.3% |
| Q2 2016 | $1,447,000 | +589.0% | 18,600 | +830.0% | 0.01% | +600.0% |
| Q4 2015 | $210,000 | -90.5% | 2,000 | -90.4% | 0.00% | -88.9% |
| Q3 2015 | $2,201,000 | -31.5% | 20,900 | -11.1% | 0.01% | -35.7% |
| Q2 2015 | $3,214,000 | -51.1% | 23,500 | -55.4% | 0.01% | -53.3% |
| Q1 2015 | $6,567,000 | +418.7% | 52,700 | +276.4% | 0.03% | +500.0% |
| Q4 2014 | $1,266,000 | +208.0% | 14,000 | +145.6% | 0.01% | +150.0% |
| Q3 2014 | $411,000 | -69.8% | 5,700 | -74.0% | 0.00% | -66.7% |
| Q2 2014 | $1,362,000 | +140.6% | 21,900 | +163.9% | 0.01% | +200.0% |
| Q1 2014 | $566,000 | -69.3% | 8,300 | -68.3% | 0.00% | -71.4% |
| Q4 2013 | $1,843,000 | -39.6% | 26,200 | -38.1% | 0.01% | -36.4% |
| Q3 2013 | $3,053,000 | -25.7% | 42,300 | -42.6% | 0.01% | -26.7% |
| Q2 2013 | $4,108,000 | – | 73,700 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 146,800 | $12,161,000 | 0.12% |
| Hudson Bay Capital Management LP | 50,000 | $4,142,000 | 0.04% |
| SIMPLEX TRADING, LLC | 404 | $225,000 | 0.01% |
| Timber Hill LLC | 12,100 | $1,002,000 | 0.01% |
| JPMORGAN CHASE & CO | 40,000 | $3,314,000 | 0.00% |
| SG Americas Securities, LLC | 14,000 | $130,000 | 0.00% |